title: Sipuleucel-T.
authors.forename: Celestia S
authors.initials: CS
authors.lastname: Higano
authors.forename: Eric J
authors.initials: EJ
authors.lastname: Small
authors.forename: Paul
authors.initials: P
authors.lastname: Schellhammer
authors.forename: Uma
authors.initials: U
authors.lastname: Yasothan
authors.forename: Steven
authors.initials: S
authors.lastname: Gubernick
authors.forename: Peter
authors.initials: P
authors.lastname: Kirkpatrick
authors.forename: Philip W
authors.initials: PW
authors.lastname: Kantoff
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D023381:Endpoint Determination; D006801:Humans; D007167:Immunotherapy; D008297:Male; D009000:Monocytes / Q000276:immunology; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000276:immunology; D016032:Randomized Controlled Trials as Topic; D014020:Tissue Extracts / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D014020:Tissue Extracts; C511774:sipuleucel-T